SunWay Biotech Co

SunWay Biotech Co Liabilities

The The Liabilities of SunWay Biotech Co (1271.TWO) as of Oct 20, 2026 is 1.20 B TWD. In the previous year, The Liabilities was 527.13 M TWD — a change of 127.27% (higher).

Liabilities

1.20 BTWD

YoY

127.27%

Last updated:

In 2025, SunWay Biotech Co's total liabilities amounted to 1.20 B TWD, a 127.27% difference from the 527.13 M TWD total liabilities in the previous year.

The SunWay Biotech Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
38.58 M TWD
Jan 1, 2020
46.53 M TWD
Jan 1, 2021
60.65 M TWD
Jan 1, 2022
190.14 M TWD
Jan 1, 2023
455.11 M TWD
Jan 1, 2024
527.13 M TWD
Jan 1, 2025
1.20 B TWD
The SunWay Biotech Co Liabilities history
YEARLiabilitiesYoY
1.20 BTWD+127.27%
527.13 MTWD+15.82%
455.11 MTWD+139.35%
190.14 MTWD+213.51%
60.65 MTWD+30.34%
46.53 MTWD+20.61%
38.58 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SunWay Biotech Co Stock analysis

What does SunWay Biotech Co do? SunWay Biotech Co., Ltd. generates revenue through the research, development, manufacture, and sale of red yeast health food products. The company's main products include Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which target digestive health, bacterial ecology regulation, immunity, and allergy management. These products are sold in both domestic and overseas markets, catering to consumers seeking natural health solutions. The firm focuses on health food segments where digestive and immune support are key consumer needs. The company's product portfolio emphasizes specific strains like Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which are marketed for their functional benefits in digestion and immune regulation. These health foods are distributed across domestic and international channels, targeting health-conscious consumers who prioritize natural remedies. SunWay Biotech leverages its research-driven approach to position these products in the health food market. SunWay Biotech Co., Ltd. operates within the health food industry, focusing on products that address digestive and immune health through natural ingredients. Its offerings are designed to improve bacterial ecology in the digestive tract and regulate immunity and allergies, appealing to a segment of consumers interested in preventive health solutions. The company's domestic and overseas market strategy ensures broad reach for its specialized health food products. SunWay Biotech Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing SunWay Biotech Co's Liabilities

SunWay Biotech Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SunWay Biotech Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing SunWay Biotech Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

SunWay Biotech Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in SunWay Biotech Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about SunWay Biotech Co stock

The Liabilities of SunWay Biotech Co is 1.20 B TWD in 2025.

The Liabilities of SunWay Biotech Co changed from 527.13 M TWD to 1.20 B TWD, representing a 127.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities SunWay Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's SunWay Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — SunWay Biotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — SunWay Biotech Co